Drug Shortage Report for BI-PEGLYTE
| Report ID | 203635 |
| Drug Identification Number | 02326302 |
| Brand name | BI-PEGLYTE |
| Common or Proper name | BI-PEGLYTE |
| Company Name | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | POTASSIUM CHLORIDE SODIUM CHLORIDE SODIUM BICARBONATE SODIUM SULFATE POLYETHYLENE GLYCOL 3350 BISACODYL |
| Strength(s) | 0.76G 1.46G 1.69G 5.74G 59.55G 5MG |
| Dosage form(s) | POWDER FOR SOLUTION KIT TABLET (DELAYED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | KIT |
| ATC code | A06AB |
| ATC description | DRUGS FOR CONSTIPATION |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-09-05 |
| Actual start date | 2023-09-05 |
| Estimated end date | 2024-05-15 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-04-12 |
| Company comments | Limited quantities available. Product Allocation |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-04-12 | French | Compare |
| v5 | 2024-04-12 | English | Compare |
| v4 | 2023-09-06 | English | Compare |
| v3 | 2023-09-05 | French | Compare |
| v2 | 2023-09-05 | English | Compare |
| v1 | 2023-09-05 | English | Compare |
Showing 1 to 6 of 6